Insider Transactions in Q2 2022 at Cigna Corp (CI)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2022
|
Jason D Sadler Pres., International Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,104
+3.25%
|
$153,456
$139.22 P/Share
|
|
Jun 28
2022
|
Jason D Sadler Pres., International Health |
SELL
Open market or private sale
|
Direct |
3,458
-9.82%
|
$933,660
$270.0 P/Share
|
|
Jun 28
2022
|
Jason D Sadler Pres., International Health |
BUY
Exercise of conversion of derivative security
|
Direct |
3,458
+8.94%
|
$480,662
$139.22 P/Share
|
|
May 18
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,869
+4.47%
|
$944,280
$120.89 P/Share
|
|
May 17
2022
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
45,261
-11.28%
|
$12,220,470
$270.79 P/Share
|
|
May 17
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,261
+18.03%
|
$5,431,320
$120.89 P/Share
|
|
Apr 27
2022
|
William J De Laney Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+3.32%
|
-
|
|
Apr 27
2022
|
Eric J Foss Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+2.18%
|
-
|
|
Apr 27
2022
|
Neesha Hathi Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+34.66%
|
-
|
|
Apr 27
2022
|
Kathleen M Mazzarella Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+15.37%
|
-
|
|
Apr 27
2022
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+15.37%
|
-
|
|
Apr 27
2022
|
George Kurian Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+29.19%
|
-
|
|
Apr 27
2022
|
Kimberly A. Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+22.75%
|
-
|
|
Apr 27
2022
|
Elder Granger Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+13.9%
|
-
|
|
Apr 27
2022
|
Donna F Zarcone Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+2.67%
|
-
|
|
Apr 27
2022
|
Eric C Wiseman Director |
BUY
Grant, award, or other acquisition
|
Direct |
757
+3.45%
|
-
|
|
Apr 26
2022
|
John Partridge Director |
BUY
Grant, award, or other acquisition
|
Direct |
188
+0.66%
|
-
|
|
Apr 21
2022
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
863
+2.28%
|
$119,957
$139.22 P/Share
|
|
Apr 21
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,749
+4.61%
|
$929,880
$120.89 P/Share
|
|
Apr 20
2022
|
Nicole S Jones Officer |
SELL
Open market or private sale
|
Direct |
5,918
-14.1%
|
$1,568,270
$265.0 P/Share
|
|
Apr 20
2022
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,918
+12.36%
|
$822,602
$139.22 P/Share
|
|
Apr 20
2022
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
45,380
-4.97%
|
$12,116,460
$267.45 P/Share
|
|
Apr 20
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,004
+21.11%
|
$6,360,480
$120.89 P/Share
|
|
Apr 19
2022
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
41,788
-7.91%
|
$10,906,668
$261.35 P/Share
|
|
Apr 19
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,788
+18.27%
|
$5,014,560
$120.89 P/Share
|
|
Apr 19
2022
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
844
+2.29%
|
$117,316
$139.22 P/Share
|
|
Apr 18
2022
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
3,717
-1.26%
|
$966,420
$260.89 P/Share
|
|
Apr 18
2022
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,717
+2.44%
|
$446,040
$120.89 P/Share
|
|
Apr 18
2022
|
Nicole S Jones Officer |
SELL
Open market or private sale
|
Direct |
12,070
-13.7%
|
$3,126,130
$259.05 P/Share
|
|
Apr 18
2022
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,936
+11.16%
|
$825,104
$139.22 P/Share
|
|
Apr 07
2022
|
Eric P Palmer Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,311
+3.1%
|
$102,258
$78.03 P/Share
|
|
Apr 06
2022
|
Everett Neville EVP, Solutions & Corp Devt. |
SELL
Open market or private sale
|
Direct |
999
-12.18%
|
$249,750
$250.0 P/Share
|
|
Apr 06
2022
|
Jason D Sadler Pres., International Health |
SELL
Open market or private sale
|
Direct |
5,000
-13.61%
|
$1,250,000
$250.0 P/Share
|
|
Apr 06
2022
|
Eric P Palmer Officer |
SELL
Open market or private sale
|
Direct |
8,126
-17.02%
|
$2,031,500
$250.0 P/Share
|
|
Apr 06
2022
|
Eric P Palmer Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,656
+12.23%
|
$519,168
$78.03 P/Share
|